American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Norfolk Southern
NSC
|
$305M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$204M |
| 3 |
Texas Instruments
TXN
|
$204M |
| 4 |
FMC
FMC
|
$162M |
| 5 |
F5
FFIV
|
$156M |
Top Sells
| 1 |
PepsiCo
PEP
|
$361M |
| 2 |
Pfizer
PFE
|
$247M |
| 3 |
iShares Russell Mid-Cap Value ETF
IWS
|
$231M |
| 4 |
Colgate-Palmolive
CL
|
$199M |
| 5 |
Union Pacific
UNP
|
$192M |
Sector Composition
| 1 | Technology | 19.15% |
| 2 | Healthcare | 16.32% |
| 3 | Financials | 15.25% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$829B
| $495M | 0.59% | 5,499,957 -280,035 | -5% | -$25.2M |
|
27
MSCI
MSCI
$43.9B
| $489M | 0.58% | 1,691,165 +31,113 | +2% | +$8.99M |
|
28
TJX Companies
TJX
$152B
| $484M | 0.58% | 10,127,805 -333,617 | -3% | -$16M |
|
29
Regeneron Pharmaceuticals
REGN
$61.5B
| $475M | 0.57% | 972,763 -36,672 | -4% | -$17.9M |
|
30
Kimberly-Clark
KMB
$42.8B
| $458M | 0.55% | 3,579,414 -495,958 | -12% | -$63.4M |
|
31
Hubbell
HUBB
$22.9B
| $449M | 0.53% | 3,909,690 +323,762 | +9% | +$37.1M |
|
32
Adobe
ADBE
$151B
| $430M | 0.51% | 1,350,605 +66,519 | +5% | +$21.2M |
|
33
Merck
MRK
$210B
| $427M | 0.51% | 5,551,510 +1,065,475 | +24% | +$82M |
|
34
Northern Trust
NTRS
$25B
| $424M | 0.51% | 5,619,754 +1,753,102 | +45% | +$132M |
|
35
Quest Diagnostics
DGX
$20.3B
| $423M | 0.5% | 5,262,604 -304,663 | -5% | -$24.5M |
|
36
Walmart
WMT
$774B
| $422M | 0.5% | 3,715,847 +21,106 | +0.6% | +$2.4M |
|
37
Applied Materials
AMAT
$128B
| $421M | 0.5% | 9,181,974 -1,812,668 | -16% | -$83.1M |
|
38
GDS Holdings
GDS
$6.62B
| $413M | 0.49% | 7,132,374 -664,162 | -9% | -$38.5M |
|
|
INFO
39
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $408M | 0.49% | 6,799,714 +287,907 | +4% | +$17.3M |
|
40
PNC Financial Services
PNC
$81.7B
| $407M | 0.48% | 4,250,862 -12,455 | -0.3% | -$1.19M |
|
41
Biogen
BIIB
$19.4B
| $406M | 0.48% | 1,281,956 -32,955 | -3% | -$10.4M |
|
|
MXIM
42
DELISTED
Maxim Integrated Products
MXIM
| $396M | 0.47% | 8,154,137 -731,497 | -8% | -$35.6M |
|
43
Cummins
CMI
$54.9B
| $394M | 0.47% | 2,910,348 +59,007 | +2% | +$7.98M |
|
|
44
Pfizer
PFE
$141B
| $389M | 0.46% | 11,910,433 -7,569,629 | -39% | -$247M |
|
|
45
Norfolk Southern
NSC
$62.8B
| $386M | 0.46% | 2,641,121 +2,090,388 | +380% | +$305M |
|
46
Teleflex
TFX
$5.59B
| $385M | 0.46% | 1,315,736 +231,001 | +21% | +$67.7M |
|
47
American Express
AXP
$231B
| $364M | 0.43% | 4,256,020 -91,300 | -2% | -$7.82M |
|
48
Chipotle Mexican Grill
CMG
$56.5B
| $360M | 0.43% | 550,550 +37,574 | +7% | +$24.6M |
|
49
Starbucks
SBUX
$100B
| $358M | 0.43% | 5,452,646 +1,532,027 | +39% | +$101M |
|
50
Estee Lauder
EL
$33B
| $356M | 0.42% | 2,234,874 +245,694 | +12% | +$39.1M |
|